|
Nov 15
|
Athira Pharma Presents Preclinical Data Highlighting Fosgonimeton’s Neuroprotective Effects Against Amyloid-β-Induced Pathological Alterations and Neuroinflammation in Models of Alzheimer’s Disease
|
|
Nov 15
|
Athira Pharma Insiders Placed Bullish Bets Worth US$556.3k
|
|
Aug 10
|
Athira Pharma Reports Second Quarter 2023 Financial Results and Pipeline and Business Updates
|
|
Apr 25
|
Athira Pharma Presents New Clinical and Preclinical Data at the American Academy of Neurology (AAN) 2023 Annual Meeting
|